Archive summary Clinical
Topic
Depression
Every article tagged “Depression”, newest first. Part of the Clinical & research section.
248 articles · page 1 of 7 · May 4, 2026 – Jun 7, 2026
Archive summary Clinical
Monitoring Reveals Elevated Antidepressant Levels in Some Waterways
Depression, anxiety and sleep disorders are among the conditions often treated with antidepressant drugs. Yet, up to 90% of these drugs pass through the body into…
Archive summary Clinical
NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.
Osmind presented a retrospective comparative study of de-identified electronic health record data in a sample of 8,224 patients with treatment resistant depression…
Archive summary Clinical
BioVie Eyes Summer Catalyst as Parkinson’s, Long COVID Trial Readouts Near
BioVie (NASDAQ:BIVI) President and CEO Cuong Do said during a RedChip Companies webinar that the company expects two near-term clinical readouts for its lead drug…
Archive summary Clinical
MUSC treatment helps patients recover from depression in days
Researchers at the Medical University of South Carolina said a breakthrough treatment for severe depression is helping some patients recover in days rather than months.
Archive summary Clinical
Frontman Of Popular CT Cover Band Battling Stage 4 Cancer Diagnosis
Fans are rallying to support a Shelton resident and longtime musician through a stage 4 cancer diagnosis.
Archive summary Clinical
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced the pricing of an underwritten public offering of 5,714,286 shares of common stock at a…
Archive summary Clinical
NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
NRx Pharmaceuticals, a clinical-stage biopharmaceutical company, announced plans for an underwritten public offering of common stock with BTIG, LLC as lead bookrunner…
Archive summary Clinical
Clearmind Medicine Advances Global Intellectual Property Portfolio with Japanese Patent Filing for Innovative Psychedelic- Based Depression Treatment
Vancouver, Canada, May 29, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on…
Archive summary Clinical
MedCheck: FDA Approves Novel Antipsychotic Milsaperidone; Designates Psilocybin Analogue as Breakthrough Therapy for Postpartum Depression, and More
Archive summary Clinical
PaCCSC clinical trials | University of Technology Sydney
PaCCSC clinical trials investigate better quality of life options for people in palliative care.
Archive summary Clinical
RFK Jr.’s Push to Curb Antidepressants Has Shaken Psychiatry
Most years, when thousands of psychiatrists gather for the annual meeting of the American Psychiatric Association, they walk past a scattering of protesters. There are…
Archive summary Clinical
Citius Pharmaceuticals (NASDAQ:CTXR) versus NRx Pharmaceuticals (NASDAQ:NRXP) Head-To-Head Contrast
Citius Pharmaceuticals (NASDAQ:CTXR – Get Free Report) and NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report) are both small-cap medical companies, but which is the…
Archive summary Clinical
Can we harness quantum effects to create a new kind of healthcare?
Experiments hint that quantum mechanisms are vital to the machinery of life. Now researchers are exploring if these effects help to explain the success of an array of…
Archive summary Clinical
Surprising drug combo could reshape suicide treatment
The study showed immediate clinical applications, the researchers said, but others urged taking a wait-and-see approach.
Archive summary Clinical
Compass Pathways Q1 Earnings Call Highlights
Compass Pathways (NASDAQ:CMPS) said it has begun a rolling New Drug Application submission for COMP360, its investigational psilocybin treatment for treatment-resistant…
Archive summary Clinical
Antidepressants Safe in Pregnancy, No Added Risk of Autism or ADHD in Kids
There's no clear link between antidepressant use during pregnancy and autism or ADHD in children, according to a new evidence review spanning more than half a million…
Archive summary Clinical
Huge Study Torpedoes Fears: Antidepressants In Pregnancy Not Tied To Autism Or ADHD
A Lancet Psychiatry meta‐analysis found no meaningful association between common antidepressants used around pregnancy and autism or ADHD once parental factors were…
Archive summary Clinical
Antidepressants and pregnancy: What parents-to-be should know about ADHD, autism risks
By Kristen Rogers, CNN (CNN) — Concerns about whether antidepressants cause harms to developing fetuses, including neurodevelopmental disorders, have grown in recent…
Archive summary Clinical
Taking antidepressants during pregnancy has little to no link to ADHD, autism
By Kristen Rogers, CNN (CNN) — Concerns about whether antidepressants cause harms to developing fetuses, including neurodevelopmental disorders, have grown in recent…
Archive summary Clinical
Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company focused on accelerating patient access to evidence-based innovation in mental health, announced that…
Archive summary Clinical
Moms' stress and depression is compromising babies before they're even born
The U.S. has among the worst maternal and infant health outcomes in the developed world. The mental health of mothers may be part of the problem..
Archive summary Clinical
Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder
Definium Therapeutics announced that the first patient has been dosed in Ascend, its second Phase 3 pivotal study evaluating DT120 ODT (lysergide tartrate) for the…
Archive summary Clinical
Federal Initiative Aims to Curb Antidepressant Overprescription
A new federal initiative aims to curb overprescribing of psychiatric medications while emphasizing holistic care.
Archive summary Clinical
New Therapy Rewires the Brain To Restore Joy in Depression Patients
Anhedonia reduces the ability to feel joy and affects nearly 90% of people with major depression. Most conventional therapies do little to treat it. Most people think of…
Archive summary Clinical
Bruno Vision Care Wins 2026 MedTech Breakthrough Award
Archive summary Clinical
Kennedy’s officials explored restrictions on antidepressants
WASHINGTON U.S. health department officials last week explored whether they could ban certain drugs in a widely prescribed class of antidepressants as Health Secretary…
Archive summary Clinical
Psychedelic therapy may help some patients – and seriously harm others
A new study shows that psychedelic therapy does not work the same for everyone. Patient traits, lifestyle, and preparation influence results.
Archive summary Clinical
InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Clearance for Depression and Suicidality Trial
NRx Pharmaceuticals (NASDAQ: NRXP) announced that the U.S. Food and Drug Administration cleared the company to initiate a Phase 2/3 clinical trial evaluating NRX-101 in…
Archive summary Clinical
Feds Hand Madison Mushroom Lab a Golden Ticket in Depression Drug Race
Usona Institute won a federal voucher to accelerate FDA review of psilocybin for major depression after an April 18 executive order prioritizing psychedelic therapies.
Archive summary Clinical
Kennedy launches bold initiative to curb antidepressant dependency, sparking national debate
(NaturalNews) HHS Secretary Robert F. Kennedy Jr. announced initiatives targeting SSRI antidepressants, which 16.6% of U.S. adults currently take. The plan e...
Archive summary Clinical
RFK Jr.’s Antidepressant Crackdown: Heroin Analogies Ignite Clash Over America’s Pill Habits
HHS Secretary RFK Jr. launches initiatives to cut antidepressant use, equating SSRI withdrawal to heroin based on anecdotes. Experts rebut with data showing low…
Archive summary Clinical
AFSP Statement on the Importance of Antidepressants and Evidence-Based Treatment for Suicide Prevention
NEW YORK, May 5, 2026 /PRNewswire/ -- On May 4, 2026, the U.S. Department of Health and Human Services (HHS) released an action plan aimed at addressing concerns about…
Archive summary Clinical
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that…
Archive summary Clinical
Magnus Expands Access to 5-Day SAINT® Depression Therapy as Leading Health Systems Scale Nationwide Adoption
Archive summary Clinical
Networknewsbreaks Nrx Pharmaceuticals, Inc. (NASDAQ: NRXP) Initiates First Commercial Manufacturing Order For Preservative-Free Ketamine
NRx Pharmaceuticals (NASDAQ: NRXP) announced it has initiated its first commercial manufacturing order of preservative-free ketamine in anticipation of potential ...
Archive summary Clinical
NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Initiates First Commercial Manufacturing Order For Preservative-Free Ketamine
NRx Pharmaceuticals (NASDAQ: NRXP) announced it has initiated its first commercial manufacturing order of preservative-free ketamine in anticipation of potential…
Archive summary Clinical
ZAP-X System Debuts in Taiwan, Anchoring Next-Generation Neuro-Oncology Program at KSCH
Archive summary Clinical
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Initiation of Commercial Manufacturing for Preservative Free Ketamine
NRXP is manufacturing and commercializing preservative free ketamine.
Archive summary Clinical
TN clears way for clinical trials of ibogaine, same drug classification as LSD
Tennessee is moving forward with clinical trials of ibogaine, a controversial psychedelic drug recently fast-tracked for research by the Trump administration.
Newsletter
The weekly digest
Weekly digest of US behavioral health policy and regulation, source-linked and practitioner-edited. Free; unsubscribe in one click.